Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Breast Cancer Research and Treatment|April 1, 1995
A phase III randomized trial of cyclophosphamide, mitoxantrone, and 5-fluorouracil (CNF) versus cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in patients with metastatic breast cancerM C Alonso, J M Tabernero, B Ojeda, et al.
Medicina Clinica|September 20, 2000
[Prospective assessment of clinical outcomes in patients with lung cancer]X Bonfill, J Montes, M Roqué, et al.
Archivos Espanoles De Urologia|January 1, 1992
[Follow-up of patients with localized germinal testicular tumors: 6 years' experience at the "Santa Creu i Sant Pau" Hospital]M A Climent Duran, J R Germa Lluch, M A Seguí Palmer, et al.
Actas Urologicas Espanolas|January 1, 1991
[Does total androgen suppression in advanced prostatic cancer induce a greater number of complete remissions? A phase II trial]J R Germà Lluch, M A Izquierdo Delso, M A Seguí Palmer, et al.
Seminars in Oncology|March 4, 2000
Ifosfamide and irinotecan in solid tumors: a phase I dose-finding trialA J Moyano, M A Seguí, T Abad, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 30, 2016
SEOM Clinical Guideline of fertility preservation and reproduction in cancer patients (2016)M Muñoz, A Santaballa, M A Seguí, et al.
European Urology|January 1, 1992
Intensive chemotherapy in poor-prognosis nonseminomatous germ cell tumors of the testisJ R Germá Lluch, M A Seguí Palmer, M A Climent Durán, et al.
American Journal of Clinical Oncology|August 26, 1998
Anticachectic efficacy of megestrol acetate at different doses and versus placebo in patients with neoplastic cachexiaC Vadell, M A Seguí, J M Giménez-Arnau, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 12, 2013
Bevacizumab plus preoperative chemotherapy in operable HER2 negative breast cancer: biomarkers and pathologic responseP Sánchez-Rovira, M A Seguí, A Llombart, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 7, 2010
Phase II clinical trial of liposomal-encapsulated doxorubicin citrate and docetaxel, associated with trastuzumab, as neoadjuvant treatment in stages II and IIIA HER2-overexpressing breast cancer patients. GEICAM 2003-03 studyA Antón, A Ruiz, A Plazaola, et al.
Pageof 3